Michael Scolaro

Michael Scolaro

Aug 29, 2017

Group 6 Copy 200
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    Ebola video voice-over recording in 10 African local languages

    Ebola virus is spreading rapidly in West Africa. We are sharing a 3D animation explaining the symptoms of the...

    Decreasing the Risk of Death and Diving Injuries in Artisanal Fishermen

    Artisanal fishermen risk their lives every day to support their families and communities. Using outdated technology...

    Backer Badge Funded